Biblio

Export 3142 results:
Author Title Type [ Year(Asc)]
2015
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M., “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
H. Jang, Kim, J. Hun, Choi, S. Hye, Lee, Y., Hong, C. Hyung, Jeong, J. Hyang, Han, H. Jeong, Moon, S. Young, Park, K. Won, Han, S. - H., Park, K. Hyung, Kim, H. Jin, Na, D. L., and Seo, S. Won, “Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F., “Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
K. Matsuzono, Yamashita, T., Ohta, Y., Hishikawa, N., Sato, K., Kono, S., Deguchi, K., Nakano, Y., and Abe, K., “Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).”, J Alzheimers Dis, vol. 46, no. 3, pp. 687-93, 2015.
C. E. Gleason, Fischer, B. L., N Dowling, M., Setchell, K. D. R., Atwood, C. S., Carlsson, C. M., and Asthana, S., “Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
D. Kelly, Coen, R. F., Akuffo, K. Owusu, Beatty, S., Dennison, J., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., and Nolan, J. M., “Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.”, J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., “Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
L. A. Johnson, Gamboa, A., Vintimilla, R., Cheatwood, A. J., Grant, A., Trivedi, A., Edwards, M., Hall, J. R., and O'Bryant, S. E., “Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.”, J Alzheimers Dis, vol. 47, no. 1, pp. 129-36, 2015.
K. Nho, Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., and Saykin, A. J., “Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults.”, J Alzheimers Dis, 2015.
C. Balducci, Paladini, A., Micotti, E., Tolomeo, D., La Vitola, P., Grigoli, E., Richardson, J. C., and Forloni, G., “The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.”, J Alzheimers Dis, 2015.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., “Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
C. Conejero-Goldberg, Hyde, T. M., Chen, S., Herman, M. M., Kleinman, J. E., Davies, P., and Goldberg, T. E., “Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.”, J Alzheimers Dis, 2015.
L. Calderón-Garcidueñas, Mora-Tiscareño, A., Sánchez, G. Melo, Rodríguez-Díaz, J., Torres-Jardón, R., Styner, M., Mukherjee, P. S., Lin, W., and Jewells, V., “A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.”, J Alzheimers Dis, 2015.
D. N. Kiosses, Rosenberg, P. B., McGovern, A., Fonzetti, P., Zaydens, H., and Alexopoulos, G. S., “Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia.”, J Alzheimers Dis, vol. 48, no. 2, pp. 453-62, 2015.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., “Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.”, J Alzheimers Dis, 2015.
Q. Zhao, Roberts, R. O., Ding, D., Cha, R., Guo, Q., Meng, H., Luo, J., Machulda, M. M., V Pankratz, S., Wang, B., Christianson, T. J. H., Aakre, J. A., Knopman, D. S., Boeve, B. F., Hong, Z., and Petersen, R. C., “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
G. J. Brewer, “Divalent Copper as a Major Triggering Agent in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
G. Giaccone, “The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.”, J Alzheimers Dis, 2015.
H. H. Hansen, Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. Bjerre, Farr, S. A., and Vrang, N., “The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
J. Thomas- Ric Keeney, Ibrahimi, S., and Zhao, L., “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.”, J Alzheimers Dis, vol. 48, no. 2, pp. 411-24, 2015.
S. Meier, Bell, M., Lyons, D. N., Ingram, A., Chen, J., Gensel, J. C., Zhu, H., Nelson, P. T., and Abisambra, J. F., “Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.”, J Alzheimers Dis, 2015.
E. Moyse, Bastin, C., Salmon, E., and Brédart, S., “Impairment of Age Estimation from Faces in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., “Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
R. Migliaccio, Agosta, F., Possin, K. L., Canu, E., Filippi, M., Rabinovici, G. D., Rosen, H. J., Miller, B. L., and Gorno-Tempini, M. Luisa, “Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, 2015.

Pages